Falmina Kit
Product Images NDC 16714-359

8 FDA label images from Northstar Rx Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Falmina (NDC 16714-359). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagrams of the active ingredients levonorgestrel and ethinyl estradiol. Each structure includes molecular formulas (C21H28O2 for levonorgestrel and C20H24O2 for ethinyl estradiol) and molecular weights (312.45 and 296.40, respectively).*
FDA Label Image

Table1 (Table1)

Table1 (Table1)
A data table showing mean and standard deviation pharmacokinetic parameters of levonorgestrel and ethinyl estradiol over a 21-day dosing period. Parameters include Cmax, Tmax, AUC, CL/F, Vz/F, and SHBG for levonorgestrel, unbound levonorgestrel metrics, and concentration and clearance parameters for ethinyl estradiol on days 1, 6, and 21.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
Pharmacokinetic concentration-time profiles for levonorgestrel and ethinyl estradiol over 72 hours on days 1, 6, and 21 of dosing. The left graph shows levonorgestrel concentration (ng/mL) and the right graph shows ethinyl estradiol concentration (pg/mL) with error bars indicating variability. Concentration declines over time for all days.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A forest plot showing effect estimates from various studies comparing hormonal contraceptive use versus non-use. The horizontal axis represents effect estimates ranging from -1.50 to 2.00, with studies listed on the left side. The plot includes odds ratios, relative risks, and hazard ratios with confidence intervals depicted as horizontal lines across the effect estimate axis.*
FDA Label Image

Figure4 (Figure4)

Figure4 (Figure4)
Blister card packaging for Falmina, a prescription kit containing 28 tablets of levonorgestrel and ethinyl estradiol USP 0.10 mg/0.02 mg. The card is organized in four weekly rows, with active orange tablets for weeks 1-3 and inactive white tablets for week 4. The card includes dosing days marked Sunday through Saturday and instructions to start at week 1, with storage and manufacturer details for Northstar Rx LLC.*
FDA Label Image

Figure5 (Figure5)

Figure5 (Figure5)
Illustration showing how to select and place the correct day label on a Falmina (levonorgestrel and ethinyl estradiol) oral contraceptive kit blister pack. The image depicts a hand peeling a day label to align with the pill pack days (Sunday to Friday) for correct usage tracking, with example active and inactive tablets marked by color.*
FDA Label Image
FDA Label Image

Carton (Carton)

Carton (Carton)
Falmina (levonorgestrel and ethinyl estradiol) Tablets, USP 0.1 mg/0.02 mg kit packaging label. The label indicates it contains 3 blister packs with 28 tablets each for a 28-day regimen. The labeler is Northstar Rx LLC. The label features black and orange text with a floral image and includes barcodes, lot, expiration information placeholders, and dispensing instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.